Pediatric herpes zoster in North Africa: clinical features and complications

Read full text Summarise with VIRAT
Authors: Fatima Zahrae-Mernissi, Hanane Baybay, Meryem Soughi, Sara Elloudi, Sofia El Haitamy, Zakia Douhi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective: To characterize the clinico-epidemiological profile, complications, and outcomes of pediatric herpes zoster (HZ) at a North African tertiary center. Method: Retrospective review of children < 18 years with clinical HZ (unilateral dermatomal vesicular rash) from February 2016 to April 2025. Results: Twenty patients (M: F 1.86:1; mean age 7.13 ± 3.77 years). Most (85%) were immunocompetent; three had chemotherapy-treated malignancies. Pruritus predominated (50%), followed by pain (20%). Thoracic dermatomes were most common (55%), then trigeminal (30%; ocular involvement in 4). Acute complications affected 60%: bacterial superinfection (30%), zoster keratitis (20%). No neurological sequelae or post-herpetic neuralgia occurred. 95% received oral antivirals. Lesions resolved within two weeks, except one immunocompetent child with permanent dyschromic macules and hypertrophic scarring. Conclusion: Pediatric HZ mainly affects immunocompetent children in our setting and carries substantial acute complication risk, especially trigeminal. Early recognition and prompt antivirals are essential to minimize morbidity. Consider HZ in any child with dermatomal vesicular rash, irrespective of immune status.

Fields of Study & Subjects

Herpesvirus Infections and Treatments Cytomegalovirus and herpesvirus research Virology and Viral Diseases

Publication details

Journal / source
Portuguese Journal of Dermatology and Venereology
Volume
84
Issue
2
Publication date
5 June 2026
Language
EN